• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    Geron Corporation (GERN)

    -NasdaqGS
    2.62 Down 0.25(8.57%) 3:59PM EST
    |After Hours : 2.63 Up 0.01 (0.57%) 5:12PM EST - Nasdaq Real Time Price
    Prev Close:2.86
    Open:2.83
    Bid:2.59 x 2000
    Ask:2.63 x 2100
    1y Target Est:7.50
    Beta:2.5957
    Next Earnings Date:N/A
    Day's Range:2.58 - 2.84
    52wk Range:2.58 - 5.30
    Volume:3,439,830
    Avg Vol (3m):3,072,740
    Market Cap:413.75M
    P/E (ttm):N/A
    EPS (ttm):-0.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GERN

    Comparison

    Symbol% ChgMkt Cap
    GERNDown 8.57%413.75M
    BMYUp 1.83%101.30B
    GSKDown 3.16%95.52B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.46
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.00
    Quarterly EPS Est (Dec-15) :-0.05
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback